Company record
Wells Pharma of Houston, LLC
1 FDA warning letter since 2023 and 7 recalls in the last 12 months.
Get an email the day FDA posts anything new about Wells Pharma of Houston, LLC.
Warning letters
-
DrugsWells Pharma of Houston, LLC
Compounding Pharmacy/Adulterated Drug Products
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31. cGMP deviations. |
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65. cGMP deviations. |
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03. cGMP deviations. |
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02. cGMP deviations. |
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25. cGMP deviations. |
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03 cGMP deviations. |
| May 6 | Class II | Wells Pharma of Houston LLC Drug |
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15. cGMP deviations. |